After vaccinations, she developed an adequate peptide-specific CD4+ T-cell response and she obtained a stable MR5 still lasting today after 17 years without any further CML therapy [21]. The gene discussed is CD4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.